The purpose of the study is to investigate if long-term treatment with three known drugs (acetylsalicylic acid, 1α 25-dihydroxy cholecalciferol, and calcium carbonate) prevents recurrence of colorectal adenomas.
This is a multicenter, randomized, parallel group, prospective, double blind, placebo controlled clinical trial of chemoprevention in patients at increased risk of developing colorectal cancer (CRC). The Colotech combination treatment (acetylsalicylic acid, 1α 25-dihydroxy cholecalciferol, and calcium carbonate) will be compared to placebo with regards to safety and efficacy during 3 years of treatment. The randomized treatment period will be preceded by a 3-week single blind placebo run-in period, which will assess patient's compliance to treatment. In order to collect data on the durability of treatment effect, follow-up data from a surveillance colonoscopy will be collected two years after the 3-year colonoscopy.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Enrollment
350
Assessment of cumulative frequency of recurrence of colorectal adenomas post ablation
The purpose of the study is to investigate if long-term treatment with three known drugs (acetylsalicylic acid, 1α 25-dihydroxy cholecalciferol, and calcium carbonate) prevents recurrence of colorectal adenomas which were removed during colonoscopy.
Time frame: 156 weeks
Assessment of number and size of colorectal adenomas measured after three years of chemoprevention using the study drug
The purpose of the study is to investigate if long-term treatment with three known drugs (acetylsalicylic acid, 1α 25-dihydroxy cholecalciferol, and calcium carbonate) prevents recurrence of colorectal adenomas which were removed during colonoscopy.
Time frame: 3 years
Assessment of durability of polyp-free colon post surgical ablation for two years post-treatment with chemoprevention with study drug
The purpose of the study is to investigate if long-term treatment with three known drugs (acetylsalicylic acid, 1α 25-dihydroxy cholecalciferol, and calcium carbonate) prevents recurrence of colorectal adenomas which were removed during colonoscopy.
Time frame: additional 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Alabama Digestive Disorders Center, P.C.
Huntsville, Alabama, United States
San Diego Digestive Disease Consultants, Inc.
San Diego, California, United States
Advance Digestive Care
Clearwater, Florida, United States
Internal Medicine Specialists
Orlando, Florida, United States
Atlanta Center for Gastroenterology, PC
Decatur, Georgia, United States
Central Indiana Gastroenterology Group
Anderson, Indiana, United States
Gastrointestinal Clinic of Quad Cities
Davenport, Iowa, United States
University of Kentucky Medical Center
Lexington, Kentucky, United States
Gastroenterology Associates of Eastern Maine
Bangor, Maine, United States
Digestive Disorders Associates
Annapolis, Maryland, United States
...and 29 more locations